AMPH FY 2016 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$255M+1.4% YoY

Gross Profit

$104M40.8% margin

Operating Income

$16M6.1% margin

Net Income

$11M4.1% margin

EPS (Diluted)

$0.22

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$17M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$428M

Total Liabilities

$98M

Stockholders' Equity

$329M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$255M	$252M	+1.4%
Gross Profit	$104M	$77M	+34.7%
Operating Income	$16M	-$7M	+327.5%
Net Income	$11M	-$3M	+477.9%